Philippe L Bedard (Philippe Bedard, Philippe L Bédard)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 54

Top Topics

Venous Thromboembolism

Papillary Thyroid

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs, Ashley Newcomb, Asha Postle, Jeremy L Warner, Michele L LeNoue-Newton, Shawn M Sweeney, Shirin Pillai, Celeste Yu, Chelsea Nichols, Brooke Mastrogiacomo, Ritika Kundra, Nikolaus Schultz, Kenneth L Kehl, Gregory J Riely, Deborah Schrag, Anand Govindarajan, Katherine S Panageas, Philippe L Bedard
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry. Cancer research communications 4 (2) (2024)
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah E Fuchs, Gregory J Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard, Shawn M Sweeney, Michael Fiandalo, Katherine S Panageas, null null
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set. JCO precision oncology 8 (2024)
Lucia Bogdan, Ramy R Saleh, Lisa Avery, Samanta Del Rossi, Celeste Yu, Philippe L Bedard
Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center. JCO precision oncology 8 (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. Cancer discovery 14 (6) (2024)
Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs, Ashley Newcomb, Asha Postle, Jeremy L Warner, Michele L LeNoue-Newton, Shawn M Sweeney, Shirin Pillai, Celeste Yu, Chelsea Nichols, Brooke Mastrogiacomo, Ritika Kundra, Nikolaus Schultz, Kenneth L Kehl, Gregory J Riely, Deborah Schrag, Anand Govindarajan, Katherine S Panageas, Philippe L Bedard
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry. Cancer research communications 4 (2) (2024)
Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard, Andres Cervantes, Valentina Gambardella, Erika Paige Hamilton, Antoine Italiano, Kevin M Kalinsky, Ian E Krop, Mafalda Oliveira, Peter Schmid, Cristina Saura, Nicholas C Turner, Andrea Varga, Sravanthi Cheeti, Stephanie Hilz, Katherine E Hutchinson, Yanling Jin, Stephanie Royer-Joo, Ubong Peters, Noopur Shankar, Jennifer L Schutzman, Dejan Juric
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah E Fuchs, Gregory J Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard, Shawn M Sweeney, Michael Fiandalo, Katherine S Panageas, null null
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set. JCO precision oncology 8 (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah E Fuchs, Gregory J Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard, Shawn M Sweeney, Michael Fiandalo, Katherine S Panageas, null null
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set. JCO precision oncology 8 (2024)
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, Ming Han, Zhihui Amy Liu, A Hal K Berman, Anna Spreafico, Albiruni Abdul Razak, Stéphanie Lheureux, Aaron Richard Hansen, Deborah Lo Giacco, Farnoosh Abbas-Aghababazadeh, Judith Matito, Benjamin Haibe-Kains, Trevor J Pugh, Scott V Bratman, Meenakshi Malhotra, Roger Berche, Omar Saavedra, Elena Garralda, Sawako Elston, Lillian L Siu, Pamela S Ohashi, Ana Vivancos, Philippe L Bedard
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO precision oncology 8 (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs, Ashley Newcomb, Asha Postle, Jeremy L Warner, Michele L LeNoue-Newton, Shawn M Sweeney, Shirin Pillai, Celeste Yu, Chelsea Nichols, Brooke Mastrogiacomo, Ritika Kundra, Nikolaus Schultz, Kenneth L Kehl, Gregory J Riely, Deborah Schrag, Anand Govindarajan, Katherine S Panageas, Philippe L Bedard
Genomic characterization and clinical outcomes of patients with peritoneal metastases from the AACR GENIE Biopharma Collaborative colorectal cancer registry. Cancer research communications (2024)
Alberto Hernando-Calvo, S Y Cindy Yang, Maria Vila-Casadesús, Ming Han, Zhihui Amy Liu, A Hal K Berman, Anna Spreafico, Albiruni Abdul Razak, Stéphanie Lheureux, Aaron Richard Hansen, Deborah Lo Giacco, Farnoosh Abbas-Aghababazadeh, Judith Matito, Benjamin Haibe-Kains, Trevor J Pugh, Scott V Bratman, Meenakshi Malhotra, Roger Berche, Omar Saavedra, Elena Garralda, Sawako Elston, Lillian L Siu, Pamela S Ohashi, Ana Vivancos, Philippe L Bedard
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab. JCO precision oncology 8 (2024)
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah E Fuchs, Gregory J Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard, Shawn M Sweeney, Michael Fiandalo, Katherine S Panageas, null null
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set. JCO precision oncology 8 (2024)
Eric Y Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, Derek Wong, Kayla Marsh, Albiruni Abdul Razak, Anna Spreafico, Philippe L Bedard, Aaron Richard Hansen, Stéphanie Lheureux, Dax Torti, Bernard Lam, Shih Yu Cindy Yang, Justin M Burgener, Ping Luo, Yong Zeng, Nicholas Cheng, Phillip Awadalla, Scott V Bratman, Pamela S Ohashi, Trevor J Pugh, Lillian L Siu
Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors. Cancer discovery (2024)
Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah E Fuchs, Gregory J Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard, Shawn M Sweeney, Michael Fiandalo, Katherine S Panageas, null null
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set. JCO precision oncology 8 (2024)
Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs, Ashley Newcomb, Asha Postle, Jeremy L Warner, Michele L LeNoue-Newton, Shawn M Sweeney, Shirin Pillai, Celeste Yu, Chelsea Nichols, Brooke Mastrogiacomo, Ritika Kundra, Nikolaus Schultz, Kenneth L Kehl, Gregory J Riely, Deborah Schrag, Anand Govindarajan, Katherine S Panageas, Philippe L Bedard
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry. Cancer research communications 4 (2) (2024)
Scott C Lien, Dalam Ly, S Y Cindy Yang, Ben X Wang, Derek L Clouthier, Michael St Paul, Ramy Gadalla, Babak Noamani, Carlos R Garcia-Batres, Sarah Boross-Harmer, Philippe L Bedard, Trevor J Pugh, Anna Spreafico, Naoto Hirano, Albiruni R A Razak, Pamela S Ohashi
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature communications 15 (1) (2024)
Abdulazeez Salawu, Ben X Wang, Ming Han, Caryn Geady, Alya Heirali, Hal K Berman, Thomas D Pfister, Alberto Hernando-Calvo, Esmail Mutahar Al-Ezzi, Lee-Anne Stayner, Abha A Gupta, Olubukola Ayodele, Bernard Lam, Aaron Richard Hansen, Anna Spreafico, Philippe L Bedard, Marcus O Butler, Lisa Avery, Bryan Coburn, Benjamin Haibe-Kains, Lillian L Siu, Albiruni Abdul Razak
Safety, immunologic and clinical activity of Durvalumab in combination with Olaparib or Cediranib in advanced leiomyosarcoma: Results of the DAPPER clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Noura J Choudhury, Jessica A Lavery, Samantha Brown, Ino De Bruijn, Justin Jee, Thinh Ngoc Tran, Hira A Rizvi, Kathryn C Arbour, Karissa A Whiting, Ronglai Shen, Matthew D Hellmann, Philippe L Bedard, Celeste Yu, Natasha B Leighl, Michele L LeNoue-Newton, Christine M Micheel, Jeremy L Warner, Michelle S Ginsberg, Andrew J Plodkowski, Jeffrey Girshman, Peter Sawan, Shirin Pillai, Shawn M Sweeney, Kenneth L Kehl, Katherine S Panageas, Nikolaus Schultz, Deborah Schrag, Gregory J Riely
The GENIE BPC NSCLC cohort: a real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, Qiuxiang Ou, Daniel Vilarim Araújo, Albiruni Abdul Razak, Aaron Richard Hansen, Anna Spreafico, Hua Bao, Xue Wu, Lillian L Siu, Philippe L Bedard
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials. JCO precision oncology 7 (2023)
Lawson Eng, Rinku Sutradhar, Yue Niu, Ning Liu, Ying Liu, Yosuf Kaliwal, Melanie Lynn Powis, Geoffrey Liu, Jeffrey M Peppercorn, Philippe L Bedard, Monika K Krzyzanowska
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Josep Tabernero, Philippe L Bedard, Yung-Jue Bang, Maria Vieito, Min-Hee Ryu, Nathalie Fagniez, Mustapha Chadjaa, Christine Soufflet, Nina Masson, Anas Gazzah
Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens. Cancer research communications 3 (8) (2023)
Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy Shih-Hsin Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B. JCO precision oncology 6 (2022)
John Hilton, Karen Gelmon, Philippe L Bedard, Dongsheng Tu, Hong Xu, Anna V Tinker, Rachel Goodwin, Scott A Laurie, Derek Jonker, Aaron R Hansen, Zachary W Veitch, Daniel J Renouf, Linda Hagerman, Hongbo Lui, Bingshu E Chen, Deb Kellar, Irene Li, Sung-Eun Lee, Takako Kono, Brian Yu Chieh Cheng, Damian Yap, Daniel Lai, Sean Beatty, John Soong, Kathleen I Pritchard, Isabel Soria-Bretones, Eric Chen, Harriet Feilotter, Moira Rushton, Lesley Seymour, Samuel A J R Aparicio, David W Cescon
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies. Nature communications 13 (1) (2022)
Michele L LeNoue-Newton, Sheau-Chiann Chen, Thomas Stricker, David M Hyman, Natalie Blauvelt, Philippe L Bedard, Funda Meric-Bernstam, Rinaa S Punglia, Deborah Schrag, Eva M Lepisto, Fabrice Andre, Lillian M Smyth, Semih Dogan, Celeste Yu, Chetna Wathoo, Mia A Levy, Lisa D Eli, Feng Xu, Grace Mann, Alshad S Lalani, Fei Ye, Christine M Micheel, Monica Arnedos
Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Jessica A Lavery, Eva M Lepisto, Samantha Brown, Hira Rizvi, Caroline McCarthy, Michele LeNoue-Newton, Celeste Yu, Jasme Lee, Xindi Guo, Thomas V Yu, Julia Rudolph, Shawn Sweeney, null null, Ben Ho Park, Jeremy L Warner, Philippe L Bedard, Gregory J Riely, Deborah Schrag, Katherine S Panageas
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach. JCO clinical cancer informatics 6 (2022)
Adam Bobrowski, Lynn Anson-Cartwright, Kopika Kuhathaas, Di Maria Jiang, Peter Chung, Philippe L Bedard, Padraig Warde, Martin O'Malley, Joan Sweet, Robert J Hamilton
Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance. The Journal of urology 208 (6) (2022)
Anna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, Philippe L Bedard, Lillian L Siu
The Future of Clinical Trial Design in Oncology. Cancer discovery 11 (4) (2022)
Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R Abdul Razak, Anna Spreafico, Philippe L Bedard, Lillian L Siu, Lori M Minasian, Aaron Richard Hansen
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials. Journal of the National Cancer Institute 113 (8) (2022)
Susan J Done, Nisha Kanwar, Zaldy Balde, Ranju Nair, Melanie Dawe, Shiyi Chen, Manjula Maganti, Atenafu G Eshetu, Sabrina Manolescu, Carrie X Wei, Amanda Mao, Fred Fu, Dan Wang, Alison Cheung, Yulia Yerofeyeva, Rachel Peters, Kela Liu, Christine Desmedt, Christos Sotiriou, Borbala Szekely, Janina Kulka, Trevor D McKee, Naoto Hirano, Timothy J Whelan, Martin Joel Yaffe, Philippe L Bedard, David McCready
Heterogeneity of circulating tumor cell-associated genomic gains in breast cancer and its association with the host immune response. Cancer research (2021)
Ritika Kundra, Hongxin Zhang, Robert Sheridan, Sahussapont Joseph Sirintrapun, Avery Wang, Angelica Ochoa, Manda Wilson, Benjamin Gross, Yichao Sun, Ramyasree Madupuri, Baby A Satravada, Dalicia Reales, Efsevia Vakiani, Hikmat A Al-Ahmadie, Ahmet Dogan, Maria Arcila, Ahmet Zehir, Steven B Maron, Michael F Berger, Cristina Viaplana, Katherine Janeway, Matthew D Ducar, Lynette Sholl, Snjezana Dogan, Philippe L Bedard, Lea F Surrey, Iker Huerga Sanchez, Aijaz Syed, Anoop Balakrishnan Rema, Debyani Chakravarty, Sarah Suehnholz, Moriah H Nissan, Gopakumar V Iyer, Rajmohan Murali, Nancy Bouvier, Robert A Soslow, David M Hyman, Anas Younes, Andrew M Intlekofer, James J Harding, Richard D Carvajal, Paul J Sabbatini, Ghassan K Abou-Alfa, Luc G T Morris, Yelena Y Janjigian, Meighan M Gallagher, Tara A Soumerai, Ingo K Mellinghoff, Abraham Ari Hakimi, Matthew Fury, Jason T Huse, Aditya Bagrodia, Meera R Hameed, Stacy B Thomas, Stuart M Gardos, Ethan Cerami, Tali Mazor, Priti Kumari, Pichai Raman, Priyanka Shivdasani, Suzanne P MacFarland, Scott Newman, Angela Waanders, Jianjiong Gao, David B Solit, Nikolaus Schultz
OncoTree: A Cancer Classification System for Precision Oncology. JCO clinical cancer informatics 5 (2021)
Curigliano Giuseppe, André B P van Kuilenburg, Nicolas Mach, Toshihiko Doi, David Tai, Patrick M Forde, John Sarantopoulos, Philippe L Bedard, Chia-Chi Lin, F Stephen Hodi, Sofie Wilgenhof, Armando Santoro, Catherine A Sabatos-Peyton, Tyler A Longmire, Alexandros Xyrafas, Haiying Sun, Sabine Gutzwiller, Luigi Manenti, Aung Naing
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Daniel Vilarim Araújo, Ao Wang, Dax Torti, Alberto Leon, Kayla Marsh, Aoife McCarthy, Hal K Berman, Anna Spreafico, Aaron R Hansen, Albiruni-Abdul Razak, Philippe L Bedard, Lisa Wang, Eric Plackmann, Helen Chow, Hua Bao, Xue Wu, Trevor J Pugh, Lillian L Siu
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy. JNCI cancer spectrum 5 (3) (2021)
Eoghan R Malone, Jeremy Lewin, Xuan Li, Wen-Jiang Zhang, Susan Lau, Keith Jarvi, Robert J Hamilton, Aaron Richard Hansen, Eric X Chen, Philippe L Bedard
Semen and serum platinum levels in cisplatin-treated survivors of germ cell cancer. Cancer medicine 11 (3) (2021)
Michael J Raphael, Sumit Gupta, Xuejiao Wei, Yingwei Peng, Claudio N Soares, Philippe L Bedard, D Robert Siemens, Andrew G Robinson, Christopher M Booth
Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
S Y Cindy Yang, Scott C Lien, Ben X Wang, Derek L Clouthier, Youstina Hanna, Iulia Cirlan, Kelsey Zhu, Jeffrey P Bruce, Samah El Ghamrasni, Marco A J Iafolla, Marc Oliva, Aaron R Hansen, Anna Spreafico, Philippe L Bedard, Stephanie Lheureux, Albiruni Razak, Vanessa Speers, Hal K Berman, Alexey Aleshin, Benjamin Haibe-Kains, David G Brooks, Tracy L McGaha, Marcus O Butler, Scott V Bratman, Pamela S Ohashi, Lillian L Siu, Trevor J Pugh
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. Nature communications 12 (1) (2021)
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E Robson, Justin Ndozeng, Andrea Gombos, Eva Ciruelos Gil, Evandro de Azambuja, Giuseppe Viale, Elsemieke D Scheepers, Curigliano Giuseppe, Judith M Bliss, Jorge S Reis-Filho, Marco Colleoni, Marija Balić, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans P M W Wildiers, Angel L Guerrero-Zotano, Peter S Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Ásgerdur Sverrisdóttir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E Davidson, Oskar Th Johannsson, Philippe L Bedard, Sherene Loi, Susan Knox, David A Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandão, Andrea Vingiani, Carmela Caballero, Florentine S Hilbers, Lucy R Yates, Matteo Benelli, David Venet, Martine J Piccart
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. Cancer discovery 11 (11) (2021)
Aaron Richard Hansen, Kari Ala-Leppilampi, Chris McKillop, Lillian L Siu, Philippe L Bedard, Albiruni R Abdul Razak, Anna Spreafico, Srikala S Sridhar, Natasha Leighl, Marcus O Butler, David Hogg, Adrian Sacher, Amit M Oza, Rany Al-Agha, Catherine Maurice, Christopher T Chan, Shane Shapera, Jordan J Feld, Rosane Nisenbaum, Kimberly Webster, David Cella, Janet Parsons
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs. Cancer 126 (7) (2020)
Scott V Bratman, S Y Cindy Yang, Marco A J Iafolla, Zhihui Liu, Aaron R Hansen, Philippe L Bedard, Stephanie Lheureux, Anna Spreafico, Albiruni Abdul Razak, Svetlana Shchegrova, Maggie Louie, Paul Billings, Bernhard Zimmermann, Himanshu Sethi, Alexey Aleshin, Dax Torti, Kayla Marsh, Jenna Eagles, Iulia Cirlan, Youstina Hanna, Derek L Clouthier, Scott C Lien, Pamela S Ohashi, Wei Xu, Lillian L Siu, Trevor J Pugh
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab. Nature cancer 1 (9) (2020)
Kari Ala-Leppilampi, Natalie A Baker, Chris McKillop, Marcus O Butler, Lillian L Siu, Anna Spreafico, Albiruni R Abdul Razak, Anthony M Joshua, David Hogg, Philippe L Bedard, Natasha Leighl, Amit M Oza, Janet A Parsons, Aaron Richard Hansen
Cancer patients' experiences with immune checkpoint modulators: A qualitative study. Cancer medicine 9 (9) (2020)
Lillian M Smyth, Qin Zhou, Bastien Nguyen, Celeste Yu, Eva M Lepisto, Monica Arnedos, Michael J Hasset, Michele L Lenoue-Newton, Natalie Blauvelt, Semih Dogan, Christine M Micheel, Chetna Wathoo, Hugo Mark Horlings, Jan Hudecek, Benjamin E Gross, Ritika Kundra, Shawn M Sweeney, JianJiong Gao, Nikolaus Schultz, Andrew Zarski, Stuart M Gardos, Jocelyn Lee, Seth Sheffler-Collins, Ben H Park, Charles L Sawyers, Fabrice André, Mia A Levy, Funda Meric-Bernstam, Philippe L Bedard, Alexia Iasonos, Deborah Schrag, David M Hyman, null null
Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry. Cancer discovery 10 (4) (2020)
Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, Caroline H Williams-Gray, Philippe L Bedard, Steven M Rowe, Francesca Morgante, Alfonso Fasano, Benjamin Stecher, Marcelo A Kauffman, Matthew J Farrer, Chris S Coffey, Michael A Schwarzschild, Todd Sherer, Ronald B Postuma, Antonio P Strafella, Andrew B Singleton, Roger A Barker, Karl Kieburtz, C Warren Olanow, Andres Lozano, Jeffrey H Kordower, Jesse M Cedarbaum, Patrik Brundin, David G Standaert, Anthony E Lang
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology 94 (11) (2020)
Komal Jhaveri, Matthew T Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R Patel, Vincent Ribrag, Cynthia X Ma, Raid Aljumaily, Philippe L Bedard, Jasgit C Sachdev, Lara Dunn, Helen H Won, John Bond, Surai Jones, Heidi M Savage, Maurizio Scaltriti, Timothy R Wilson, Michael C Wei, David M Hyman
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Yada Kanjanapan, Daphne Day, Lisa Wang, Hamad Al-Sawaihey, Engy Abbas, Amirali Namini, Lillian L Siu, Aaron Hansen, Albiruni Abdul Razak, Anna Spreafico, Natasha Leighl, Anthony M Joshua, Marcus O Butler, David Hogg, Mary Anne Chappell, Ludmilla Soultani, Kayla Chow, Samantha Boujos, Philippe L Bedard
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities. Cancer 125 (8) (2019)
Rina Hui, Alex Pearson, Javier Cortes, Christine Campbell, Camille Poirot, Hatem A Azim, Debora Fumagalli, Matteo Lambertini, Fergus Daly, Amal Arahmani, José Perez-Garcia, Philippe Aftimos, Philippe L Bedard, Laura Xuereb, Elsemieke D Scheepers, Malou Vicente, Theodora Goulioti, Sibylle Loibl, Sherene Loi, Marie-Jeanne Pierrat, Nicholas C Turner, Fabrice Andre, Curigliano Giuseppe
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (2) (2019)
Vandana G Abramson, Mafalda Oliveira, Andrés Cervantes, Hans Wildiers, Manish R Patel, Todd M Bauer, Philippe L Bedard, Carlos Becerra, Stephen Richey, Michael C Wei, Eric Reyner, John Bond, Na Cui, Timothy R Wilson, Heather M Moore, Cristina Saura, Ian E Krop
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer. Breast cancer research and treatment 178 (1) (2019)
Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, Anna Patrikidou, Eitan Amir, Christoph Seidel, Carsten Bokemeyer, Christian Fankhauser, Thomas Hermanns, Alexey Rumyantsev, Alexey Tryakin, Margarida Brito, Aude Fléchon, Edmond Michael Kwan, Tina Cheng, Daniel Castellano, Xavier Garcia Del Muro, Anis A Hamid, Margaret Ottaviano, Giovannella Palmieri, Robert Kitson, Alison Reid, Daniel Y C Heng, Philippe L Bedard
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3). Cancer medicine 9 (1) (2019)
Tira Jing Ying Tan, Michael Rheaume, Lisa Wang, Helen Chow, Anna Spreafico, Aaron Richard Hansen, Albiruni Abdul Razak, Lillian L Siu, Philippe L Bedard
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era. The oncologist 24 (7) (2019)
Maura N Dickler, Cristina Saura, Donald A Richards, Ian E Krop, Andrés Cervantes, Philippe L Bedard, Manish R Patel, Lajos Pusztai, Mafalda Oliveira, Alison K Cardenas, Na Cui, Timothy R Wilson, Thomas J Stout, Michael C Wei, Jerry Y Hsu, José Baselga
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (18) (2018)
Rossanna C Pezo, Tom W Chen, Hal K Berman, Anna M Mulligan, Albiruni A Razak, Lillian L Siu, David W Cescon, Eitan Amir, Christine Elser, David G Warr, Srikala S Sridhar, Celeste Yu, Lisa Wang, Tracy L Stockley, Suzanne Kamel-Reid, Philippe L Bedard
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. Breast cancer research and treatment 168 (1) (2017)
Philippe L Bedard, Michael A Davies, Scott Kopetz, Dejan Juric, Geoffrey I Shapiro, Jason J Luke, Anna Spreafico, Bin Wu, Christelle Castell, Corinne Gomez, Sylvaine Cartot-Cotton, Florent Mazuir, Michel Dubar, Sandrine Micallef, Brigitte Demers, Keith T Flaherty
First-in-human trial of the PI3Kβ-selective inhibitor SAR260301 in patients with advanced solid tumors. Cancer 124 (2) (2017)